Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Oct;41(5):444-6.
doi: 10.1136/ard.41.5.444.

High-dose intravenous methylprednisolone in rheumatoid arthritis

P J Forster, K A Grindulis, V Neumann, S Hubball, B McConkey

High-dose intravenous methylprednisolone in rheumatoid arthritis

P J Forster et al. Ann Rheum Dis. 1982 Oct.

Abstract

Fourteen patients with severe rheumatoid arthritis (RA) were given 27 courses of methylprednisolone intravenously, each of 3 infusions of 1 g on alternate days. After 7 days there was marked improvement in clinical state and most laboratory tests; levels of ESR and 4 serum acute-phase proteins, C3, C, IgG, and IgA, fell significantly. Serum IgM and rheumatoid factor titre were unchanged. 125I C1q binding fell in all instances where it was initially raised. Clinical remission lasted a mean of 10 weeks. Serum C-reactive protein (CRP) fell to less than 30 mg/l after all courses except one within 7 days and rose above this figure after a mean of 7 weeks. The ESR fell below 30 mm/h within seven days in 17 courses and remained below this value for a mean of 7 weeks. Three patients had clinical remissions, with serum CRP less than 30 mg/l and ESR less than 30 mm/h, lasting more than 42 weeks.

PubMed Disclaimer

References

    1. Q J Med. 1972 Apr;41(162):115-25 - PubMed
    1. Am J Med. 1973 Apr;54(4):461-72 - PubMed
    1. Ann Rheum Dis. 1973 Nov;32(6):557-64 - PubMed
    1. Q J Med. 1973 Oct;42(168):785-91 - PubMed
    1. J Immunol. 1976 Jan;116(1):232-5 - PubMed

Publication types